Related Experiment Video
Updated: Sep 21, 2026

The Green Monster Process for the Generation of Yeast Strains Carrying Multiple Gene Deletions
Published on: December 15, 2012
Transcriptional control of multidrug resistance in the yeast Saccharomyces
1Department of Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242, USA.
Abstract:
A major problem in chemotherapeutic treatment of many pathological conditions including cancer and fungal infections is the development of a multidrug-resistant state in the target cell. Saccharomyces cerevisiae cells can be isolated that have single genetic alterations that cause the resulting mutant strains to become tolerant of a wide range of compounds that would otherwise be toxic. These mutant cells are referred to as having a pleiotropic drug-resistant (Pdr) phenotype. Studies of these Pdr cells have demonstrated that mutations either within genes encoding transcriptional regulators or in their regulatory inputs lead to overexpression of downstream transporter proteins with associated multidrug resistance. This review is aimed at providing a framework for understanding the networks modulating expression of PDR genes in S. cerevisiae.
Insights
Multidrug resistance in Saccharomyces cerevisiae is a significant challenge. This review explores the genetic networks that control pleiotropic drug resistance (PDR) genes, offering a framework for understanding cellular defense mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Multidrug resistance (MDR) in target cells, including those in cancer and fungal infections, poses a major challenge in chemotherapeutic treatments.
- Certain genetic alterations in Saccharomyces cerevisiae can lead to a pleiotropic drug-resistant (PDR) phenotype, conferring tolerance to a wide spectrum of toxic compounds.
- The PDR phenotype in yeast is often associated with the overexpression of transporter proteins, driven by mutations in transcriptional regulators or their regulatory inputs.
Purpose of the Study:
- To provide a comprehensive framework for understanding the regulatory networks that modulate the expression of PDR genes in Saccharomyces cerevisiae.
- To elucidate the molecular mechanisms underlying the development of pleiotropic drug resistance in yeast.
- To offer insights into potential strategies for overcoming drug resistance in therapeutic applications.
Main Methods:
- This review synthesizes findings from various studies investigating PDR gene expression in Saccharomyces cerevisiae.
- Analysis of genetic mutations affecting transcriptional regulators and their regulatory inputs.
- Examination of the role of transporter proteins in conferring multidrug resistance.
Main Results:
- Mutations in transcriptional regulators or their regulatory inputs lead to the overexpression of downstream transporter proteins.
- This overexpression results in a pleiotropic drug-resistant (PDR) phenotype in Saccharomyces cerevisiae.
- Understanding these networks is crucial for comprehending cellular resistance mechanisms.
Conclusions:
- The PDR network in Saccharomyces cerevisiae provides a model system for studying multidrug resistance.
- Identifying and understanding these regulatory networks can inform strategies to combat drug resistance in various pathological conditions.
- Further research into these networks may lead to novel therapeutic approaches.
Related Concept Videos
Bioreactor Controls-III
Yeast Signaling
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Translational Regulation

